Isolated cardiac sarcoidosis presenting as transient ischemic attack
- PMID: 39021491
- PMCID: PMC11252014
- DOI: 10.1002/ccr3.9035
Isolated cardiac sarcoidosis presenting as transient ischemic attack
Abstract
Key clinical message: Isolated cardiac sarcoidosis may rarely present with TIA or stroke as an initial clinical manifestation. This case highlights the necessity of a broad differential and a high degree of suspicion for cardiac sarcoidosis in a patient with new neurologic symptoms and evidence of cardiac disease.
Abstract: Cardiac sarcoidosis is a rare disease with a variety of clinical manifestations including heart failure and sudden death. Stroke as the earliest sign of disease has been described in rare cases. We present a case of a 54-year-old female with recurrent transient ischemic attacks (TIAs) of unknown etiology, initially in the absence of left ventricular dysfunction. Cardiomyopathy was later identified on echocardiography after a second TIA. Cardiac MRI was remarkable for focal left ventricular wall thinning with akinesis and dyskinesis of multiple wall segments, a right ventricular aneurysm, and diffuse myocardial late gadolinium enhancement. PET/CT showed multifocal areas of myocardial FDG uptake. At follow-up, echocardiography showed a left ventricular apical thrombus, in a previously identified thinned, akinetic region, suggesting cardioembolic origin for previous TIAs. She was started on anticoagulation therapy, prednisone, methotrexate, and adalimumab, with resolution of the thrombus and improvement in cardiac function. In conclusion, this case highlights the need to consider CS as a potential cause of cerebrovascular ischemic events in patients with few stroke risk factors but findings indicative of cardiac disease. It is essential to further explore the mechanisms behind these events and develop treatments that target their causes in this patient population.
Keywords: TIA; cardiomyopathy; sarcoidosis; stroke.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
Authors declare no conflict of interest.
Figures



Similar articles
-
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1. Ont Health Technol Assess Ser. 2010. PMID: 23074393 Free PMC article.
-
Left ventricular aneurysm and ventricular tachycardia as initial presentation of cardiac sarcoidosis.N Am J Med Sci. 2015 Mar;7(3):114-8. doi: 10.4103/1947-2714.153923. N Am J Med Sci. 2015. PMID: 25839003 Free PMC article.
-
[Imaging diagnostics of cardiac sarcoidosis].Herz. 2023 Oct;48(5):366-371. doi: 10.1007/s00059-023-05208-z. Epub 2023 Sep 8. Herz. 2023. PMID: 37682338 Review. German.
-
Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.Int J Cardiovasc Imaging. 2021 Apr;37(4):1361-1369. doi: 10.1007/s10554-020-02090-2. Epub 2020 Nov 22. Int J Cardiovasc Imaging. 2021. PMID: 33225427 Free PMC article.
-
The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.J Nucl Cardiol. 2021 Aug;28(4):1545-1552. doi: 10.1007/s12350-021-02681-z. Epub 2021 Jul 6. J Nucl Cardiol. 2021. PMID: 34228337
Cited by
-
Narrative review of adalimumab for the treatment of cardiac sarcoidosis.Heart Rhythm O2. 2025 Jan 9;6(3):368-382. doi: 10.1016/j.hroo.2024.12.012. eCollection 2025 Mar. Heart Rhythm O2. 2025. PMID: 40201681 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources